The Bleeding and Clotting Disorders Institute Peoria, IL - 61614

The Bleeding and Clotting Disorders Institute is categorized under Medical Centers in Peoria, IL and active since 2010.

The Bleeding and Clotting Disorders Institute was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number by the NAICS.

If you are seeking more information, feel free to contact Yvonne Lucas at the company’s single location by writing to 6811 North Knoxville Avenue, Suite A, Peoria, Illinois IL 61614 or by phoning (309) 692-5337. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: The Bleeding and Clotting Disorders Institute
Contact Person: Yvonne Lucas
Address: 6811 North Knoxville Avenue, Suite A, Peoria, Illinois 61614
Phone Number: (309) 692-5337
Annual Revenue (USD): Unknown
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Centers
Share This Business:

The Bleeding and Clotting Disorders Institute was started in 2010 to provide professional Medical Centers under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Yvonne Lucas for inquiries that concern The Bleeding and Clotting Disorders Institute by calling the company number (309) 692-5337, as your correspondence is most welcome. Additionally, the physical location of the single location of The Bleeding and Clotting Disorders Institute can be found at the coordinates 40.770046,-89.602633 as well as the street address 6811 North Knoxville Avenue, Suite A in Peoria, Illinois 61614.

For its online presence, you may visit The Bleeding and Clotting Disorders Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.